The introduction of atypical antipsychotics (AAPs) since the discovery of its prototypical drug
clozapine has been a revolutionary pharmacological step for treating psychotic patients as …

Movement disorders such as Parkinson's disease and dyskinesia are highly debilitating
conditions linked to oxidative stress and neurodegeneration. When available, the …

Background Tardive dyskinesia results from exposure to dopamine receptor antagonists,
such as typical and atypical antipsychotics. If clinically appropriate, clinicians often manage …

Background: Tardive dyskinesia (TD) is a movement disorder that causes involuntary,
repetitive body movements and is commonly seen in patients who are on long-term …

Tardive syndromes are a group of hyperkinetic and hypokinetic movement disorders that
occur after some delay following exposure to dopamine receptor blocking agents such as …

Tardive dyskinesia (TD), a movement disorder associated with antipsychotics, most
frequently affects the lower face and jaw muscles, but can also affect walking, breathing and …

Background: Protracted withdrawal syndrome (PWS) after stopping antidepressants
(frequently also referred to as post-acute withdrawal syndrome or PAWS) has been …

Ethnopharmacological relevance A widely used traditional prescription, Yi-Gan San (YGS) is
a remedy for neurodegenerative disorders. The formulation consists of seven Chinese …

Purpose Tardive dyskinesia (TD) is a common but serious hyperkinetic movement disorder
and side effect of antipsychotic medications used to treat bipolar disorder (BD), major …

Cannabidiol (CBD) is a non-psychotomimetic compound from Cannabis sativa that presents
antipsychotic, anxiolytic, anti-inflammatory, and neuroprotective effects. In Parkinson's …